Should the management of radiation therapy for breast cancer be standardized? Results of a survey on current French practices in breast radiotherapy

Rep Pract Oncol Radiother. 2021 Sep 30;26(5):814-826. doi: 10.5603/RPOR.a2021.0102. eCollection 2021.

Abstract

Background: Breast cancer is the most frequent cancer in women in France. Its management has evolved considerably in recent years with a focus on reducing iatrogenic toxicity. The radiotherapy indications are validated in multidisciplinary consultation meetings; however, questions remain outstanding, particularly regarding hypofractionated radiotherapy, partial breast irradiation, and irradiation of the internal mammary chain and axillary lymph node area.

Materials and methods: An online survey was sent to 47 heads of radiotherapy departments in France. The survey consisted of 22 questions concerning indications for irradiation of the supraclavicular, internal mammary and axillary lymph node areas; irradiation techniques and modalities; prescribed doses; and fractionation.

Results: Twenty-four out of 47 centers responded (response rate of 51%). This survey demonstrated a wide variation in the prescribed dose regimen, monoisocentric radiotherapy, and indications of irradiation of the lymph node areas.

Conclusion: This survey provides insight into the current radiotherapy practice for breast cancer in France. It shows the need to standardize practices.

Keywords: breast cancer; clinical practice; radiotherapy; survey.

Publication types

  • Review